Diagnostic utility of bleeding assessment tools in congenital fibrinogen deficiencies

Samin Mohsenian1, Omid Seidizadeh1, Roberta Palla1

  • 1Università degli Studi di Milano, Department of Pathophysiology and Transplantation, Milan, Italy.

Insights

Two bleeding assessment tools, the ISTH-BAT and EN-RBD-BSS, effectively identify patients with congenital fibrinogen deficiencies (CFDs). Both tools demonstrate significant sensitivity in detecting fibrinogen deficiency and classifying bleeding severity.

Area of Science:

  • Hematology
  • Rare Diseases
  • Diagnostic Tools

Background:

  • Clinical history assessment is vital for laboratory test referrals.
  • Bleeding Assessment Tools (BATs) standardize clinical evaluation.
  • Congenital Fibrinogen Deficiencies (CFDs) require effective diagnostic tools.

Purpose of the Study:

  • To compare the diagnostic adequacy of the ISTH-BAT and EN-RBD-BSS for identifying CFD patients.
  • To analyze the correlation between BAT scores, fibrinogen levels, and clinical bleeding severity.

Main Methods:

  • Inclusion of 100 Iranian patients diagnosed with CFDs.
  • Performance of routine coagulation and fibrinogen-specific tests (Fg:Ag, Fg:C).
  • Assessment of bleeding scores using both the ISTH-BAT and EN-RBD-BSS.

Main Results:

  • A moderate, statistically significant correlation was observed between the ISTH-BAT and EN-RBD-BSS (r = .597, P < .001).
  • Both tools showed a negative correlation with fibrinogen activity (Fg:C), indicating higher scores with lower activity.
  • The ISTH-BAT and EN-RBD-BSS correctly identified 70% and 72% of patients with fibrinogen deficiencies, respectively.

Conclusions:

  • The EN-RBD-BSS, alongside the ISTH-BAT, shows utility in identifying patients with CFDs.
  • Both BATs exhibit significant sensitivity for detecting fibrinogen deficiency.
  • Bleeding severity was accurately classified in approximately two-thirds of patients by these tools.
Abstract

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.0K
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
441
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
802
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
158